Sirolimus Drug Eluting Stent
Sirolimus Drug Eluting Stent is designed to prevent restenosis by releasing sirolimus drug in a controlled manner after coronary angioplasty, ensuring long-term vessel patency.
Sirolimus Drug Eluting Stent is an advanced coronary stent used in interventional cardiology procedures to treat blocked or narrowed arteries. It features a sirolimus drug coating that inhibits smooth muscle cell proliferation, significantly reducing the chances of restenosis. The stent ensures controlled drug release over time, promoting natural healing of the vessel while maintaining lumen integrity. It is engineered for excellent deliverability, flexibility, and precise placement, making it highly effective in complex coronary interventions.
Advanced Features:
- Sirolimus drug coating for anti-restenosis
- Controlled and sustained drug release
- Excellent flexibility and radial strength
- Smooth trackability and deployment
- Biocompatible coating for safe healing
Product Also Known As:
Sirolimus Stent, Drug Eluting Stent, Coronary DES, Cardiac Stent, Sirolimus Coated Stent, PTCA Stent, Anti-Restenosis Stent
